These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
144 related items for PubMed ID: 22554590
1. Inhibition of fatty-acid synthase suppresses P-AKT and induces apoptosis in bladder cancer. Jiang B, Li EH, Lu YY, Jiang Q, Cui D, Jing YF, Xia SJ. Urology; 2012 Aug; 80(2):484.e9-15. PubMed ID: 22554590 [Abstract] [Full Text] [Related]
2. Downregulation of fatty acid synthase complex suppresses cell migration by targeting phosphor-AKT in bladder cancer. Zheng SS, Gao JG, Liu ZJ, Zhang XH, Wu S, Weng BW, Wang YL, Hou SC, Jiang B. Mol Med Rep; 2016 Feb; 13(2):1845-50. PubMed ID: 26718084 [Abstract] [Full Text] [Related]
3. [Expression of Caspase-3 and Bcl-2 in bladder transitional carcinoma and their significance]. Shen HW, Yi L, Wang XM, Yao MJ, Deng JW, Fang JZ, Li MN. Ai Zheng; 2004 Feb; 23(2):181-4. PubMed ID: 14960240 [Abstract] [Full Text] [Related]
4. Fatty acid synthase and AKT pathway signaling in a subset of papillary thyroid cancers. Uddin S, Siraj AK, Al-Rasheed M, Ahmed M, Bu R, Myers JN, Al-Nuaim A, Al-Sobhi S, Al-Dayel F, Bavi P, Hussain AR, Al-Kuraya KS. J Clin Endocrinol Metab; 2008 Oct; 93(10):4088-97. PubMed ID: 18682509 [Abstract] [Full Text] [Related]
5. High prevalence of fatty acid synthase expression in colorectal cancers in Middle Eastern patients and its potential role as a therapeutic target. Uddin S, Hussain AR, Ahmed M, Abubaker J, Al-Sanea N, Abduljabbar A, Ashari LH, Alhomoud S, Al-Dayel F, Bavi P, Al-Kuraya KS. Am J Gastroenterol; 2009 Jul; 104(7):1790-801. PubMed ID: 19491830 [Abstract] [Full Text] [Related]
6. Therapeutic and toxicologic evaluation of anti-lipogenic agents in cancer cells compared with non-neoplastic cells. Deepa PR, Vandhana S, Jayanthi U, Krishnakumar S. Basic Clin Pharmacol Toxicol; 2012 Jun; 110(6):494-503. PubMed ID: 22151915 [Abstract] [Full Text] [Related]
7. [The clinico-pathological significance of protein expression of PAK1 in bladder transitional cell carcinoma]. Zhang YH, Xie D, Luo JH, Chen W, Chen LW, Xu QC, Liu GY, Ma HB, Lin WQ. Zhonghua Yi Xue Za Zhi; 2007 Oct 16; 87(38):2710-3. PubMed ID: 18167251 [Abstract] [Full Text] [Related]
8. [Expression of cyclooxygenase-2 in human transitional cell bladder carcinomas]. Zhan J, Tang XD. Ai Zheng; 2002 Nov 16; 21(11):1212-6. PubMed ID: 12526218 [Abstract] [Full Text] [Related]
9. Fatty acid synthase regulates proliferation and migration of colorectal cancer cells via HER2-PI3K/Akt signaling pathway. Li N, Bu X, Tian X, Wu P, Yang L, Huang P. Nutr Cancer; 2012 Aug 16; 64(6):864-70. PubMed ID: 22860766 [Abstract] [Full Text] [Related]
10. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R. Int J Oncol; 2004 Mar 16; 24(3):591-608. PubMed ID: 14767544 [Abstract] [Full Text] [Related]
11. Effects of YC-1 on hypoxia-inducible factor 1 alpha in hypoxic human bladder transitional carcinoma cell line T24 cells. Li Y, Zhao X, Tang H, Zhong Z, Zhang L, Xu R, Li S, Wang Y. Urol Int; 2012 Mar 16; 88(1):95-101. PubMed ID: 22041818 [Abstract] [Full Text] [Related]
12. Apoptosis of androgen-independent prostate cell line induced by inhibition of fatty acid synthesis. Furuya Y, Akimoto S, Yasuda K, Ito H. Anticancer Res; 1997 Mar 16; 17(6D):4589-93. PubMed ID: 9494573 [Abstract] [Full Text] [Related]
13. Fatty acid synthase inhibition induces differential expression of genes involved in apoptosis and cell proliferation in ocular cancer cells. Deepa PR, Vandhana S, Krishnakumar S. Nutr Cancer; 2013 Mar 16; 65(2):311-6. PubMed ID: 23441619 [Abstract] [Full Text] [Related]
14. Pharmacological inhibitors of mammalian fatty acid synthase suppress DNA replication and induce apoptosis in tumor cell lines. Pizer ES, Chrest FJ, DiGiuseppe JA, Han WF. Cancer Res; 1998 Oct 15; 58(20):4611-5. PubMed ID: 9788612 [Abstract] [Full Text] [Related]
15. Fatty acid synthase inhibitors induce apoptosis in non-tumorigenic melan-a cells associated with inhibition of mitochondrial respiration. Rossato FA, Zecchin KG, La Guardia PG, Ortega RM, Alberici LC, Costa RA, Catharino RR, Graner E, Castilho RF, Vercesi AE. PLoS One; 2014 Oct 15; 9(6):e101060. PubMed ID: 24964211 [Abstract] [Full Text] [Related]
16. Inhibition of Fatty Acid Synthase (FASN) synergistically enhances the efficacy of 5-fluorouracil in breast carcinoma cells. Vazquez-Martin A, Ropero S, Brunet J, Colomer R, Menendez JA. Oncol Rep; 2007 Oct 15; 18(4):973-80. PubMed ID: 17786362 [Abstract] [Full Text] [Related]
17. Loss of fatty acid synthase suppresses the malignant phenotype of colorectal cancer cells by down-regulating energy metabolism and mTOR signaling pathway. Chang L, Wu P, Senthilkumar R, Tian X, Liu H, Shen X, Tao Z, Huang P. J Cancer Res Clin Oncol; 2016 Jan 15; 142(1):59-72. PubMed ID: 26109148 [Abstract] [Full Text] [Related]
18. Pharmacological inhibition of fatty acid synthase (FAS): a novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her-2/neu (erbB-2) oncogene-induced malignant transformation. Menendez JA, Mehmi I, Verma VA, Teng PK, Lupu R. Mol Carcinog; 2004 Nov 15; 41(3):164-78. PubMed ID: 15390078 [Abstract] [Full Text] [Related]
19. Long noncoding RNA GAS5 inhibits malignant proliferation and chemotherapy resistance to doxorubicin in bladder transitional cell carcinoma. Zhang H, Guo Y, Song Y, Shang C. Cancer Chemother Pharmacol; 2017 Jan 15; 79(1):49-55. PubMed ID: 27878359 [Abstract] [Full Text] [Related]
20. Inhibition of fatty acid synthase supresses osteosarcoma cell invasion and migration. Liu ZL, Zhou Y, Luo QF, Hu M, Wang G, Huang SH, Shu Y. Indian J Pathol Microbiol; 2012 Jan 15; 55(2):163-9. PubMed ID: 22771636 [Abstract] [Full Text] [Related] Page: [Next] [New Search]